Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$23,322,684
-$116,532,339 QoQ
Shares Held
968,550
-80.6% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#260
of 2,826 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AustralianSuper Pty Ltd holds $1,190,287,072 across 9 Drug Manufacturers - General names. PFE ranks #7 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
469,702 | $563,374,716 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
1,271,457 | $160,635,877 | |
| 3 | BIIB |
Biogen Inc.
|
672,723 | $145,348,531 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
2,433,354 | $140,209,857 | |
| 5 | ABBV |
AbbVie Inc.
|
426,658 | $107,364,219 | |
| 6 | JNJ |
Johnson & Johnson
|
152,900 | $38,832,013 | |
| 7 | PFE |
Pfizer Inc
This page
|
968,550 | $23,322,684 | |
| 8 | MRK |
Merck & Co., Inc.
|
77,831 | $10,001,283 |
All Filings in PFE
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $23,322,684 | 968,550 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $139,855,023 | 4,980,592 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $115,785,796 | 4,650,032 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $101,379,161 | 3,978,774 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $55,833,422 | 2,303,359 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $8,005,767 | 315,934 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $8,381,729 | 315,934 | Shares | Sole | 2025-01-30 | |
| 2024-03-31 | $86,949,408 | 3,133,312 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $26,917,786 | 934,970 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $103,402,632 | 3,117,354 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $99,000,126 | 2,699,022 | Shares | Sole | 2023-07-28 | |
| 2022-12-31 | $126,967,391 | 2,477,896 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $100,624,763 | 2,299,469 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $26,828,974 | 518,234 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $13,686,313 | 231,775 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $20,035,520 | 465,834 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $12,367,863 | 315,829 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $11,291,876 | 311,672 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $69,411,107 | 1,885,659 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $63,002,607 | 1,716,694 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $55,077,386 | 1,684,322 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $56,926,694 | 1,744,080 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||